Find Therapeutics' mission is to emerge with a new therapeutic modality.
Employees: 1-10
Investors 2
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
| - | CTI Life S... | ctiscience... |
Mentions in press and media 4
| Date | Title | Description |
| 16.09.2024 | Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement Québec | $8.1 million convertible note financing by Investissement Québec and current investors CTI Life Sciences Fund and adMare BioInnovations MONTREAL, Sept. 16, 2024 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on t... |
| 27.08.2024 | Find Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Study of FTX-101 for the Treatment of Chronic Optic Neuropathy | Phase 1 study to assess safety of FTX-101, a therapeutic agent under development for regeneration of damaged myelin in Chronic Optic Neuropathy Company expects study to commence in Q4 2024 MONTREAL, Aug. 27, 2024 /PRNewswire/ - Find Therape... |
| 29.05.2024 | Find Therapeutics to Participate in Upcoming Conferences | MONTREAL, May 29, 2024 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced that members of the management team will participate in th... |
| 08.06.2020 | Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal | The new company raises initial capital to develop transmembrane peptides against GPCRs to address high unmet needs. Montreal, Canada – June 8, 2020: CTI Life Sciences, along with partners adMare BioInnovations, Domain Therapeutics and Pepti... |